Funder
National Natural Science Foundation of China
Reference52 articles.
1. CRISPR-Cas9 therapeutics in cancer: promising strategies and present challenges;Yi;Biochim. Biophys. Acta,2016
2. Modeling colorectal cancer using CRISPR-Cas9–mediated engineering of human intestinal organoids;Matano;Nat. Med.,2015
3. Gene therapy returns to centre stage;Naldini;Nature,2015
4. T.S. Klann, J.B. Black, M. Chellappan, A. Safi, L. Song, I.B. Hilton, G.E. Crawford, T.E. Reddy, C.A. Gersbach, CRISPR-cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome, Nat. Biotechnol. 35 (2017) 561–570.
5. CRISPR/Cas9, a powerful tool to target human herpesviruses;van Diemen;Cell. Microbiol.,2017
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献